It is obvious that a motorcar needs both an accelerator and a brake. Biological processes require this principle as well, but in a much more elaborate manner. Any organismic or cellular biological response is the result of a balance between numerous`driving' and`inhibiting' forces (Frame and Balmain, 2000) . As an impressive example, cells in an immune response are stimulated to multiply and to secrete cytokines. The response is transient, in that self-limitation is built into the response on several levels (Feldmann et al., 1996; Long, 1999; Baer et al., 1999) . This well-adjusted system can, however, be driven out of balance which leads to disease or even death of the organism. For instance, an overwhelming bacterial infection leads to septic shock. In the case of infection with a gramnegative bacterium, it is the lipopolysaccharide (LPS) receptor which, in association with the toll-like receptor Tlr4 (Hoshino et al., 1999) , triggers the massive release of TNFa and of IL1 from macrophages, obviously overwhelming the inbuilt inhibitory factors. Most aspects of the septic shock can be traced to an excessive dose of TNFa synthesized and secreted, which is supported by the facts that injection of TNFa mimics LPS in inducing septic shock (Beutler et al., 1985; Tracey and Cerami, 1994; Amiot et al., 1997) and that both TNFa and TNFRp55 knock-out mice are inhibited in their response to LPS (Pfeer et al., 1993; Pasparakis et al., 1996; Marino et al., 1997; GutierrezRamos and Bluethmann, 1997) . Less dramatic abundance of TNFa is also pathologic and indicates a failure of counteracting force. TNFa is, for instance, overproduced in joints of patients with rheumatoid arthritis (Saxne et al., 1988) , where it is responsible for the production of other cytokines, for the destruction of extracellular matrix and for tissue remodeling (Tak et al., 1996) . The best proof of this role of TNFa came from the therapeutic use of soluble TNF receptor sequestering TNFa, or of neutralizing antibodies to TNF, now used in the treatment of rheumatoid arthritis (Feldmann et al., 1996; Tak et al., 1996; Moreland et al., 1999; Maini et al., 1998) .
Several inbuilt restrictions are cell-autonomous. The signaling components between the LPS receptor and eector molecules in the nucleus, e.g. transcription factors, are under control of negative regulators, e.g. protein phosphatases counteracting the action of protein kinases, which limit the duration and magnitude of the response. In addition to cell-autonomous regulation, an organismic mechanism limits the response: the release into the circulation of cortisol in humans (corticosterone in rodents). Removal of the adrenal gland, the site of cortisol production, as well as manipulation of the levels of the glucocorticoid receptor (see below) sensitizes the organism for exaggerated immune responses including septic shock (e.g. Miller and Blake Tyrrel, 1995; Barnes, 1998; Reichardt et al., 2000) . Glucocorticoid hormone downregulates the septic shock response and counteracts in¯ammatory and immune as well as autoimmune reactions in general which makes glucocorticoids one of the most frequently prescribed drugs.
Glucocorticoid hormone acts through its speci®c receptor, the glucocorticoid receptor (GR). The GR belongs to the family of nuclear receptors (reviewed by Mangelsdorf and Evans, 1995; Beato et al., 1995) . In the absence of ligand, the GR is cytoplasmic, bound to chaperones, e.g. Hsp 90 and Hsp56, which keep the protein in a conformation ready to accept the lipophilic hormone ligand. Upon hormone binding, the GR is transported into the nucleus where it acts as a transcription factor. These properties are re¯ected in the protein structure: a central DNA binding domain (Luisi et al., 1991) , a C-terminal ligand binding domain whose ligand interaction appears to determine the accessibility of the transactivation domain AF-2 (Bourguet et al., 1995; Brzozowski et al., 1997; Shiau et al., 1998; Hu and Lazar, 1999) , and an N-terminal domain which carries the ligand-independent AF-1 (see review by Beato et al., 1995) . The active transcription factor GR is a dimer which is formed on its DNA element, the glucocorticoid response element GRE, in head-to-tail ± tail-to-head fashion. In addition to activating transcription of speci®c target genes which carry the palindromic GRE (Geisse et al., 1982; Hynes et al., 1983) , the GR exerts negative in¯uences on the expression of certain genes. In principle, all nuclear receptors seem to possess this ability Beato et al., 1995) . The expression of the nuclear receptor and the availability of ligand determines when and where receptor actions are triggered. The supply of GR seems indeed to be limiting, in that an increase in GR gene dose increased resistance to LPS-induced septic shock (Reichardt et al., 2000) . For cortisol actions one needs to take into account not only the abundance of GR. Cortisol acts as ligand for both the GR and the mineralocorticoid receptor MR (Reul and de Kloet, 1985) . In the cells of the immune system, GR is the predominant mediator of cortisol action.
Cortisol controls many organismic functions, the level of cortisol is therefore under tight control. Hypothalamic peptide hormones regulate, through the synthesis and release of ACTH, the output of cortisol from the adrenal cortex (e.g. Chrousos, 1995) . Cortisol exerts feedback control on several stages of the hypothalamus-to-adrenal gland pathway through the GR. Interestingly, neural tissues express both GR and MR which both respond to cortisol. It would make sense if only the GR requiring higher doses of cortisol than MR would be active in the feed-back control (de Kloet et al., 1993) . Downstream targets of cortisol and GR are many fold, from maintaining and in¯uencing late embryonic development through metabolic stress responses in the liver and stress protection in many organs, to hemopoietic dierentiation and behavioral endpoints (Karin, 1998) .
I will discuss here predominantly the mechanism of the anti-in¯ammatory and immune-suppressive actions of cortisol (see also previous reviews : Pfahl, 1993; Beato et al., 1995; GoÈ ttlicher et al., 1998; Karin, 1998; Epinat and Gilmore, 1999) . The cells involved in the in¯ammatory and immune responses exhibit unique features: upon stimulation they migrate (e.g. dendritic cells, T-lymphocytes) or proliferate (T and B lymphocytes). They produce and release numerous in¯amma-tory mediators, chemokines and cytokines (T cells, macrophages, endothelial cells). Inhibition by cortisol could therefore address numerous processes and the synthesis of many immune-system-speci®c proteins, e.g. adhesion molecules, cytokines, MHC components and receptors. Even selective cell death could be part of the mechanism exerted by cortisol, e.g. induction of apoptosis in CD4/CD8 double positive thymocytes and of peripheral lymphocytes. Despite this multitude of possible cortisol targets, circumstantial and some ®rm evidence (e.g. knock-outs) has reduced the problem somewhat in that a few central transcription factors and their activation pathways are responsible for a large part of the molecular features of the immune system. The transcription factors AP-1, NFkB, CREB, NF-AT and C/EBPb are responsible for most of the transcriptions relevant for the immune system (KoÈ ntgen et al., 1995;  for references see also Chinenov and Kerppola, this issue; and reviews by Pfahl, 1993; . Counteraction of the activation and activities of these transcription factors could, thus, be a mechanism by which glucocorticoids limit excessive responses of the immune system.
Cortisol-induced synthesis of speci®c inhibitors
In view of several molecular mechanisms which cortisol and the GR could establish, it is useful to classify these according to simple criteria: are the actions immediate or delayed? Do they require intermediary protein synthesis? Which step of interference can be traced: e.g. on the intracellular level a block of signal transduction between the plasma membrane and the nucleus or a block within the nucleus?
Delayed onset of inhibition occurs if a GRdependent inhibitor protein needs to be synthesized. Among GR target genes carrying GRE elements in their promoters, there may be some with`brake' properties. This most straight-forward explanation for a negative action of a transcription factor, GR, is exempli®ed by the induced transcription of the inhibitor of NF-kB: IkB. As mentioned above, cytokine gene promoters as well as those of cytokine target genes are predominantly addressed by the transcription factors AP-1 and NF-kB. Glucocorticoids were found to activate the synthesis of IkBa (Auphan et al., 1995; Scheinman et al., 1995) which limits the duration of NF-kB activity. As documented by introduction of IkB mutants which cannot be degraded, elevated IkB could prevent NF-kB activation, a mechanism which would suce to explain cortisol action on NF-kB dependent expression of genes.
It is possible that among GR target genes there are other inhibitors of transcription factors or of signal transduction, e.g. phosphatases. A precedence for the latter has been found: Dexamethasone, a non-degradable cortisol analog, inhibits JNK and Erk activation by a mechanism requiring protein synthesis (Hirasawa et al., 1998; Rider et al., 1996) . The induction of a phosphatase would be a plausible hypothesis. Interestingly, the expression of MAP kinase phosphatase, MKP-1, is enhanced by all-trans-retinoic acid possibly resulting in inhibition of JNK activity (Lee et al., 1999) . GR may also induce the synthesis of a phosphatase. Along these lines, in another slow action of a nuclear receptor induced by trans-retinoic acid the abundance of Jun protein, not the transcription of c-jun, appears to be reduced in human skin (Fisher et al., 1998) possibly by activated proteasome-dependent degradation.
Inhibition of signal transduction
The most elaborate interference by GR with proin¯ammatory and immune functions is immediate and does not require protein synthesis (van de Stolpe et al., 1993; Wissink et al., 1998) , thus suggesting a direct interference with a component of the signaling chain or with transcription factor function. With AP-1 and NFkB playing key roles in the immune response, the pathways to these transcription factors and the function of these factors caught most attention. All nuclear receptors including the GR inhibit AP-1 target gene transcription SchuÈ le et al., 1990; Yang-Yen et al., 1990; Shemshedini et al., 1991) . Although in the initial studies no interference with Jun or Fos phosphorylation was discovered (Jonat, 1990; Jonat et al., 1990) , a rapid and transcription-independent inhibition of Jun phosphorylation and of JNK activity has been reported (Caelles et al., 1997; GonzaÂ lez et al., 2000) . As JNK activity was determined by immune precipitate assay with an excess of GST-Jun as substrate, it is unlikely that the substrate was shielded from enzyme action by GR bound to the substrate. Rather ligandinduced GR or an associated factor seems to downmodulate JNK enzyme activity. In addition, JNK activity was inhibited in both cytoplasm and nucleus and nuclear uptake of JNK was not aected (GonzaÂ lez et al., 2000) . Although it is disturbing that in these experiments hormone was added 45 min prior to treatment with the JNK activating agent, the inhibition may be`immediate' which is in contrast to the delayed eect mentioned above which requires more than 6 h of hormone pretreatment. GR interferes also with the activation of Erk (but not of p38). While in endothelial cells this inhibition was rapid (GonzaÂ lez et al., 1999) , it took 18 h of hormone treatment to see the eect in mast cells (Rider et al., 1996) suggesting the involvement of intermediate steps. Also in macrophages, protein synthesis was required for MAP-kinase inhibition (Gewert et al., 2000) . It is puzzling that in certain tumor cells nuclear receptors synergize with MAP kinases, e.g. activating Erk, rather than inhibit the activation (Di Domenico et al., 1996; Peterziel et al., 1999) .
There have also been reports on cytoplasmic interference of GR-chaperone complexes with signal transduction (see e.g. Tumlin et al., 1997; Cissel and Beaven, 2000) . These are yet ill-understood and I will not discuss them in further detail. It has been proposed that signaling components associate with Hsp90 or Hsp70 the availability of which could depend on hormone-dependent release (see also review by Pratt, 1997) . Ligand-activated nuclear receptors, shown for ERa, can associate with and modulate cytoplasmic PI3-kinase (Simoncini et al., 2000) . Raf-1 and 14-3-3 coimmunopurify with GR (Widen et al., 2000) , but it is not known whether these interactions re¯ect a functional consequence.
Thus, the interference with signal transduction to critical transcription factors, e.g. AP-1, NF-kB, CREB etc., could represent the predominant immediate mechanism of GR action. However, it is plausible that the downregulation of the immune reactions is so important for the organism that safety steps exist on several levels. With respect to immediate interference by GR with components of signal transduction the exact molecular mechanisms ± cytoplasmic or nuclear, direct or involving partner components ± are yet to be resolved.
Tethering mechanisms
In addition to the proper function as a DNA-binding transcription factor, the GR has been found to modulate other transcription factors, essentially without the need for DNA contact. This was named a tethering mechanism which later turned out to occur also in other examples of transcription factors. GR modulates negatively ± in most examples proven: without DNA binding ± the activity of CREB (Akerblom et al., 1988; see also Figure 1 ; Yordanov and Rahmsdorf, unpublished), of Jun:Fos (AP-1) SchuÈ le et al., 1990; Yang-Yen et al., 1990) , of Oct-1 (Kutoh et al., 1992) , of Spi-1/PU-1 , of GATA-1 (Chang et al., 1993) and of NF-kB (Ray and Prefontaine, 1994) . Interestingly, the tethering interaction can also lead to synergy, e.g. with AP-1 or NF-kB in certain tissues or cell types (Shemshedini et al., 1991; Maroder et al., 1993; Wang et al., 1997) , with Jun homodimers (at a so-called composite element which requires however DNA binding of the GR: Diamond et al., 1990 ; as well as by pure tethering: Teurich and Angel, 1995) , with C/EBP (Nishio et al., 1993) and with Stat-5 (StoÈ cklin et al., 1996) .
Features of these tethering interactions, also called cross-talk', have been reviewed previously Karin, 1998; GoÈ ttlicher et al., 1998) . In brief, the cross-talk can be reciprocal, GR inhibiting Fos:Jun or NF-kB at their target genes, and elevated Fos or Jun or RelA (p65) interfering with GR activity at GRE promoters. Although from in vitro experiments it seemed that GR reduced AP-1 DNA binding, genomic footprints and chromatin immunoprecipitations (see below) do not support this interpretation. Rather the inhibited factor remains DNA-bound. Direct interactions of Jun with GR have been reported but their signi®cance is yet unknown. Mutual interference between AP-1 and nuclear receptors is probably not limited to the GR, but occurs with retinoic acid receptors (Lafyatis et al., 1990; Nicholson et al., 1990; SchuÈ le et al., 1990; Yang-Yen et al., 1991; Salbert et al., 1993) , estrogen receptor (Doucas et al., 1991; Shemshedini et al., 1991) , thyroid receptor (Desbois et al., 1991; Zhang et al., 1991; Lopez et al., 1993; Wondisford et al., 1993) and even the fusion receptor PML-RAR .
Oncogene Cross-talk between glucocorticoid receptor and AP-1 P Herrlich Dissociation of transrepressing and transactivating nuclear receptor function A major step towards understanding and de®ning the tethering (cross-talk) function was achieved by the detection of ligands which preferentially favor either the transrepressing or the transactivating function of nuclear receptors (for GR: VayssieÂ re et al., 1997; Vanden Berghe et al., 1999; for other nuclear receptors: Fanjul et al., 1994; . This ®nding suggested that the ligand binding domain can determine which molecular property a nuclear receptor can exhibit and that probably dierent molecular surfaces are responsible for either function. It should thus be possible to dissociate the transrepressing and transactivating function by mutation. Indeed, this has been possible. In particular, several GR mutants cannot at all or poorly transactivate, but downmodulate AP-1 and NF-kB activity by the tethering function. LS7, in the N-terminal zinc ®nger of the DNA binding domain, is a poor transactivator at GRE promoters (Godowski et al., 1989) but pro®cient in repressing AP-1 and NF-kB (Helmberg et al., 1995) . Deletions of the AF-2 can obviously not induce gene expression in response to hormone (shown for several nuclear receptors in Kamei et al., 1996) . The AF-2 mutation does, however, not aect the transrepressing function (GoÈ ttlicher, unpublished).
GR activates genes as GR dimer. The dimers form at the DNA element, but require a de®ned region of the DNA binding domain, the D-loop, to stabilize the dimer (Luisi et al., 1991; Dahlman-Wright et al., 1991) . Mutations in the D-loop severely reduce or even abolish DNA binding (Umesono and Evans, 1989; Dahlman-Wright et al., 1991; Heck et al., 1994; Reichardt et al., 1998) . It has been argued that promoters carrying an array of GREs such as the mouse mammary tumor virus promoter, may depend less on stabilization by the D-loop (Karin, 1998) . Promoters with multiple adjacent GREs are, however, the rare exception. Expression of D-loop mutants in GR-defective CV-1 cells does not confer hormoneinducible transcription of GRE promoters, but fully represses AP-1 promoters (Heck et al., 1994) .
One of the D-loop mutations, A458T, was inserted by homologous recombination using the CRE/loxP system into the mouse germ line . The GR mutant allele was called dim for dimerization defective. GR dim/dim mice are viable under animal house conditions while GR 7/7 die postnatally because of a lung maturation de®ciency which occurs for still unknown reasons (Cole et al., 1995; Tronche and Kellendonk, cited in Tronche et al., 1998) . It is clear that it is the DNA binding independent function which is required for development. Dexamethasone treatment of GR dim/dim mice does not lead to transcription of GRE target genes, e.g. of liver tyrosine aminotransferase , or of several target genes in skin (Tuckermann et al., 1999) . GRE binding assays in vitro with liver extracts of GR dim/dim mice were negative in contrast to extracts from wild type siblings. The action as a bona ®de GR transcription factor is obviously not essential during normal and protected adult life. GR dim/dim may, however, suer from certain stress conditions. For instance, hypoxia-induced erythropoiesis is impaired (Bauer et al., 1999) which is caused by de®ciency of erythroblast progenitor expansion Bauer et al., 1999) . Thus, GRE-dependent transcription is required for survival upon certain stress, but not under protected conditions. The viability of GR dim/dim mice in contrast to GR 7/7 suggests that the transcription factor modulating activities or some other DNA binding independent function are essential for life.
The D-loop mutation in the mouse permits to classify GR functions: those which depend on expression from GRE promoters or which require dimerization of the GR for some other reason, and others that are exerted by GR monomers. As had been shown by cell culture experiments (Heck et al., 1994) , phorbol ester induced expression of metalloproteases in embryonic ®broblasts and in the intact skin from GR dim/dim mice is inhibited by dexamethasone to an extent similar Figure 1 Glucocorticoids interfere with the positive and negative functions of CREB determined by the forskolin-induced transcription of c-fos, c-jun and junB (data by Iordanov and Rahmsdorf, unpublished; Ph.D. thesis Iordanov, 1996) . Quiescent NIH3T3 cells were pretreated with 10 77 M dexamethasone (D) for 15 min or not treated. Then 10 mM forskolin (F) was added and speci®c RNA levels at various times thereafter (min) were measured by Northern blotting of Poly(A) + RNA (arbitrary scale). Dexamethasone prevents the increase of c-fos and JunB abundance. Forskolin inhibits c-jun expression which is counteracted by dexamethasone after a delay of 15 min to wild type Tuckermann et al., 1999) . The metalloprotease promoters depend on AP-1 and NF-kB. Glucocorticoid-induced genes in the skin, encoding plasma glutathione peroxidase PGX-3 and Hsp 27, however, are not activated in GR dim/dim mice. Thus, the tethering reaction does not depend on GR dimerization and DNA binding.
Interestingly, the feed-back regulation of cortisol on the hypothalamus-adrenal gland axis can in part be exerted by GR monomers: CRF levels of the hypothalamus were normal as in wild type mice indicating that the control of synthesis, possibly through tethering reaction on CREB at the CRF promoter, worked in GR dim/dim mice . Neural tissues express also the MR. The MR has however no cross-talk ability as far as we know: see (Cato et al., 1992; Pearce and Yamamoto, 1993; Heck et al., 1994) ; interestingly, the GR abundance in that the hypothalamus-to-adrenal gland axis seems limiting in that the increased GR gene dosis caused downregulation of corticosterone release: (Reichardt et al., 2000) . The feed-back regulation of pituitary enzymes such as prolactin and POMC, however, did not function, as the levels of these enzymes as well as of ACTH were elevated in the pituitary of GR dim/dim . The promoters of these genes, encoding prolactin and POMC, carry speci®c DNA elements (so-called nGREs) which bind the GR and apparently in¯uence the GR to behave as a repressing factor (Sakai et al., 1988; Drouin et al., 1993) . This action requires an intact GR D-loop. The hypothesis that the DNA element or its arrangement in¯uences the structure of a transcription factor and even of those relevant here, is not without precedent: AP-1, RAR-RXR and TR have been shown to alter their conformation and function upon binding to DNA (Patel et al., 1990; Ikeda et al., 1996; Mangelsdorf et al., 1991; Chen and Evans, 1995) . Conformational changes of the GR upon interaction with GRE-like elements can be concluded both, from the detection of mutations which arrest the GR in one conformation, and from structural analyses (Starr et al., 1996; van Tiborg et al., 2000) .
Unexpectedly, ACTH serum levels of GR dim/dim mice were not elevated suggesting that there is still another level of control in the release of ACTH from the pituitary, obviously exerted by GR monomers . Nevertheless the corticosterone levels in serum were higher than in wild type. Whether this is indicative of a GR dependent control function of cortisol levels in the adrenal gland or periphery, is not yet clear.
The anti-in¯ammatory and immune suppressive function requires no dimerization and DNA binding of the GR Data that will be described below, indicate that the important physiological role of cortisol and GR in limiting undue reactions, e.g. the expansion of lymphocytes after antigenic stimulation or the unwanted overreaction to the presence of LPS, is accomplished by GR monomers. Further, the data encourage the search for agents which induce thè monomer-property' of the GR only.
Cortisol derivatives are most commonly used to combat in¯ammation and immune disease including rheumatoid arthritis and asthma. The long-term application of glucocorticoid hormones goes along with severe side eects: osteoporosis, joint necroses, inhibition of skin maintenance, hyperglycemia and other metabolic alterations (see e.g. Lukert and Raisz, 1990; Karin, 1998) . It is therefore important to know whether the therapeutic eect can be dissociated from these side eects. A ®rst step towards this distinction can be achieved by the exploitation of the GR dim/dim mouse. Can the dimerization and DNA binding defective GR mount the immune suppressive action in the adult organism? In a second more demanding step one can ask whether GR dim/dim mice develop the unwanted side eects of long-term cortisol treatment.
Indeed phorbol ester induced skin in¯ammation as measured by ear swelling could be prevented by dexamethasone in GR dim/dim (Reichardt et al., 2000 (Reichardt et al., , 2001 . Also the release of systemic TNFa and IL-6 was inhibited by dexamethasone. Mimicking a bacterial infection, LPS was injected systemically and the response monitored over time by measuring serum TNFa and IL-6. Both genotypes (GR +/+ or GR dim/dim ) responded with massive synthesis and release of both cytokines. These cytokines induced the enhanced release of glucocorticoids (through activating the hypothalamus-to-adrenal gland axis) which limited eectively the cytokine production within 3 h (Reichardt et al., 2001) ± documenting the`brake' mechanism mentioned in the introduction. The LPS dependent induction and repression of TNFa and IL-6 were reproduced in isolated macrophages (Reichardt et al., 2001) . In T lymphocytes the phorbol ester and Caionophore dependent synthesis of other cytokines, e.g. IFNg and IL-2, was also inhibited by hormone in both genotypes, GR +/+ or GR dim/dim (Reichardt et al., 2001 ). In T lymphocytes from GR dim/dim mice carrying an NFkB dependent reporter transgene, the reporter behaved like endogenous cytokine genes indicating that one of the target factors of GR repression in vivo is NF-kB in T lymphocytes. Repression occurred independently of the GR dimerization and DNA binding function and did not involve IkB synthesis in these cells . It thus seems that glucocorticoids do not induce IkB in all cell types and the induction of IkB is not required for transrepression of NF-kB (see also Heck et al., 1997; Dumont et al., 1998) .
The conclusion thus is that the immune response as determined so far, is inhibitable by cortisol in the absence of a dimerization and DNA binding function of the GR. The hope is therefore justi®ed that side eects of longterm cortisol treatment may not occur in GR dim/dim mice, which would then trigger eorts to mimick the GR dim/dim situation by speci®c GR ligands permitting only the cross-talk function to occur.
Not all immune suppressive functions of the GR could be detected in GR dim/dim mice. The killing of CD4/ Oncogene Cross-talk between glucocorticoid receptor and AP-1 P Herrlich CD8 double-positive thymocytes ± not relevant for the immune response in the adult ± in response to dexamethasone is defective ; GoÈ ttlicher, unpublished, scheme in Figure 2 ). Peripheral primary T and B lymphocytes were, however, sensitive entering apoptosis upon cortisol treatment of GR dim/dim mice (GoÈ ttlicher, unpublished). Also a T cell lymphoma line, Jurkat equipped with the GR mutant receptor LS7, were sensitive to dexamethasone-induced apoptosis (Helmberg et al., 1995) which may resemble the well-established treatment of human lymphomas and leukemia with glucocorticoids. It is likely that induced apoptosis in normal and transformed lymphocytes is mediated by the eective inhibition of cytokine release from either T cells, macrophages or autocrine tumor cells.
Molecular mechanism of cross-talk ± a working model
Previously favored model:`Competition for a coactivator, squelching'
Interference by the limited availability of CBP? The mutual nature of cross-talk between nuclear receptors Oncogene Cross-talk between glucocorticoid receptor and AP-1 P Herrlich and AP-1 or other factors suggested early on that GR and AP-1 compete for a limiting component. CBP/ p300, fairly universally requiring coactivators, seemed good candidates (Kamei et al., 1996; Aarnisalo et al., 1998) . A CBP knock-out has a severe embryonic-lethal phenotype (Yao et al., 1998) indicating that CBP is indeed a limiting component in some critical cell of early development. Moreover, the signi®cance of a CBP dose is demonstrated by the existance of a human syndrome, Rubinstein ± Taybi Syndrome, which is caused by CBP haploid insuciency (Petrij et al., 1995) suggesting that even moderate decreases in CBP abundance can aect cellular function. However, it is unlikely that the limiting abundance accounts for the repressive action of GR: Overexpression of CBP did not obliterate the inhibition of IL-6 promoter activity nor that of a GalDBD-Jun fusion dependent reporter (De Bosscher et al., 1997 . Cross-talk with dissociating mutants of the GR and the eect of dissociating ligands for RAR and GR which do not permit coactivator binding and target gene activation by the respective receptors, are not easily explainable by competion for CBP (Fanjul et al., 1994; VayssieÂ re et al., 1997; Vanden Berghe et al., 1999) . Further, one would need to assume that Jun homodimers which synergize with GR (Diamond et al., 1990; Teurich and Angel, 1995) , and Jun:ATF2 heterodimers which are not modulated by GR (unpublished data), do this by circumventing limitations for CBP while squelching occurs with Jun:Fos heterodimers. Finally, GR mutants defective in the transactivating domains AF-1 and AF-2 as well as those defective in the LBD altogether can cross-talk and unpublished) . The squelching of p300 or CBP would need to be achieved very indirectly to remain a plausible hypothesis.
Cross-talk by squelching unknown co-factors? The possibility that competition for other shared factors required by AP-1 and GR alike could be the mechanism of cross-talk, has been raised by the ®nding of conformational GR mutants which act both as negative-dominant factors on GR-driven promoters and as factors participating in cross-talk (Lefstin et al., 1994; van Tiborg et al., 2000) . Mutants S549A and P493R in the two zinc ®ngers of the DBD assumed a constitutively active conformation as if they were bound to a GRE. It is not clear, however, whether the presumed squelching mechanism by which the mutants interfere with GR wild type, is the basis of cross-talk with AP-1. Data with mutants of the genes encoding AP-1 and NF-kB which aect coactivator binding and cross-talk (SchuÈ le et al., 1990; Wissink et al., 1997) , are not yet conclusive as these mutations may have aected several properties.
A lesson from the inhibition of NF-kB by GR Against this simple squelching mechanism there is also recent data on the inhibition of NF-kB by GR. Very similarly to AP-1, NF-kB can be inhibited by GR while NF-kB remains bound to the kB promoter element. GR is tethered to the promoter by the RelA subunit. NF-kB remains DNA-bound while being inhibited as shown by genomic footprints over the kB element in the IL-2 promoter (Figure 3 and Wade, Schmitt, Herrlich and Cato, unpublished) or by chromatin immunoprecipitations of IL8 and ICAM-1 promoter elements (Nissen and Yamamoto, 2000) . Chromatin immunoprecipitations also revealed that the formation of the preinitiation complex occurred with normal eciency, not aected by hormone treatment. This suggests that the co-activator assembly occurred essentially undisturbed. However, dexamethasone blocked the phosphorylation of one of the serines (serine-2) in the cytoplasmic tail of RNA polymerase II (Nissen and Yamamoto, 2000) . Thus, GR appears to block an as yet unknown speci®c stimulus transfer between transcription factor, co-activators bound to it, and preinitiation complex.
Working model
Many new aspects have been reported in the last few years which permit us to derive a plausible model of cross-talk. The model must incorporate the following observations:
. The cross-talk between GR and other transcription factors is mutual which would be best compatible with the formation of a complex of the interfering transcription factor with the active one, a complex that will possibly involve additional partner proteins. This direct formation of a complex suggested by e.g. coprecipitation experiments Wissink et al., 1997) , has found support by genomic footprints and chromatin immunoprecipitations (see above). . Although it is possible that cross-talks between dierent factors follow dierent rules, it is attractive to postulate common mechanisms: nuclear receptors and possibly numerous other transcription factors participating in cross-talk type of modulation may share relevant properties. GR shares the cross-talk function with other nuclear receptors. These may work by the same tethering mechanism, although one branch of nuclear receptors, the RAR, RXR, TR branch, has adopted, perhaps in addition, the co-repressor mode of action. The mutual nature of cross-talk (e.g. GR modulating AP-1 and NF-kB, p65 and Fos/Jun modulating GR activity) favors the existance of a protein complex with similar functional features in both directions. . NF-kB (and presumably AP-1) are inhibited by GR after the assembly of the pre-initiation complex (Nissen and Yamamoto, 2000) . Thus probably the assembly of co-activators and TBP-associated factors is not destroyed during inhibition of transcription. Further, cross-talk, at least in the case of NF-kB/GR, does not seem to be in¯uenced by histone deacetylase inhibitors (Cronin and Yamamoto, cited in Nissen and suggesting that cross-talk does not involve the recruitment of classical co-repressors such as SMRT (Kamei et al., 1996) . . Conformational changes are made plausible by numerous observations where the DNA-element in¯uences the structure of the transcription factor. This appears true also for the GR in that a particular arrangement of triple binding sites as negative GRE seem to convert the GR into a repressing factor (Drouin et al., 1993) . Structural analyses support that DNA binding elements in¯uence factor structure (Lefstin and Yamamoto, 1998; van Tiborg et al., 2000) . It is plausible that protein-protein interactions also bring out conformation changes. . The composition of AP-1 (e.g. Jun : Fos vs Jun : Jun or Jun : ATF2) determines the positive or negative cross-talk with GR (Diamond et al., 1990; Teurich and Angel, 1995; and unpublished data) . This speci®cation of action does not depend on the DNA binding function of either transcription factor as GR shows this speci®cally also with chimeric AP-1 proteins carrying the transactivating domain fused to the DBD of Gal4 (Teurich and Angel, 1995) . . Although GR mutants dierently acting on the composite element of the proliferin gene have been screened for in yeast (Starr et al., 1996) ; the tethering cross-talk could not be reconstructed in yeast (our unpublished data) suggesting the lack of a co-factor.
A requirement for additional yet unknown factors
The co-immunoprecipitation data of kB promoters, but also the other features which need to be incorporated into a working model ± including cell-type speci®c responses and the absence of cross-talk in yeast ± highlight the need for novel factors participating in cross-talk. We envisage that the modulating factor is associated with one or several factors X which exert their yet unknown molecular function only when tethered to an active transcription complex ( Figure  4) . The modulating tethering factor has presumably not yet been switched into an`active conformation' and thus may not assemble co-activators on its own. Speci®city will be achieved by both the modulating factor and the associated X. The tethered complex would be defective in one or several last steps prior to polymerase take-o. The model implies that the factors X can be squelched/sequestered, given the binding motif has been de®ned. One may also predict that depriving cells of X e.g. by knock-out will aect both sides of the reciprocal cross-talk: e.g. releaving downmodulation of AP-1 and enhancing transcription from GRE promoters. Further that factors X will be tissuespeci®c and exert novel molecular activities.
Concluding remarks
The cross-talk ability of nuclear receptors and their partner transcription factors including AP-1 which is essential for development, was discovered 10 years ago. Much has been achieved by learning from dierent systems, particularly from the cross-talk of GR with Jun:Jun, Jun:Fos and NF-kB. It will be exciting to see how this knowledge will be made use of for glucocorticoid therapy of immune diseases.
